Xin Li

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Antiplatelet Therapy

St Segment Elevation Myocardial Infarction

Squamous Cell Carcinoma

Health Insurance

Top Venues

International journal of clinical pharmacy

Risk management and healthcare policy

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Xingyuan Gao, Man Yu, Yuyang Sun, Tiansi Zhang, Xin Li, Lingli Zhang, Changqing Wang
New Evidence of the Impact of the National Drug Price Negotiation Policy on the Availability, Utilization, and Cost of Anticancer Medicines in China: An Interrupted Time Series Study. Risk management and healthcare policy 17 (2024)
Pei Zhang, Lingli Zhang, Kai Xu, Yingtao Lin, Rui Ma, Mengdie Zhang, Xin Li
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China. International journal of clinical pharmacy 46 (2) (2024)
Pei Zhang, Lingli Zhang, Kai Xu, Yingtao Lin, Rui Ma, Mengdie Zhang, Xin Li
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China. International journal of clinical pharmacy (2024)
Jingxuan Wei, Kai Xu, Ying-Tao Lin, Qiang Liu, Chongchong Zhou, Pei Zhang, Rui Ma, Mengdie Zhang, Lingli Zhang, Xin Li
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China. International journal of clinical pharmacy (2024)
Zhiyuan Wang, Ruilin Wang, Xiaoyu Li, Lin Bai, Pingan Fan, Yuanyuan Tang, Xin Li, Yangmu Huang, Xiaoyan Nie, Sheng Han, Luwen Shi, Jing Chen
Influencing Factors of Generic Prescribing Behavior of Physicians: A Structural Equation Model Based on the Theory of Planned Behavior. Risk management and healthcare policy 17 (2024)
Pei Zhang, Lingli Zhang, Kai Xu, Yingtao Lin, Rui Ma, Mengdie Zhang, Xin Li
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China. International journal of clinical pharmacy 46 (2) (2024)
Zhiyuan Wang, Ruilin Wang, Xiaoyu Li, Lin Bai, Pingan Fan, Yuanyuan Tang, Xin Li, Yangmu Huang, Xiaoyan Nie, Sheng Han, Luwen Shi, Jing Chen
Influencing Factors of Generic Prescribing Behavior of Physicians: A Structural Equation Model Based on the Theory of Planned Behavior. Risk management and healthcare policy 17 (2024)
Lingli Zhang, Jiali Chen, Zhaoliu Cao, Mengdie Zhang, Rui Ma, Pei Zhang, Guiqing Yao, Xin Li
Patient versus physician preferences for lipid-lowering drug therapy: A discrete choice experiment. Health expectations : an international journal of public participation in health care and health policy 27 (2) (2024)
Yanhong Zhu, Xiang Sun, Maohang Cai, Jun Shi, Xin Li
Construction of a competency evaluation model for Clinical Research Coordinators in China: a study based on the Delphi method and questionnaire survey. BMJ open 14 (9) (2024)
Lingli Zhang, Jiali Chen, Zhaoliu Cao, Mengdie Zhang, Rui Ma, Pei Zhang, Guiqing Yao, Xin Li
Patient versus physician preferences for lipid-lowering drug therapy: A discrete choice experiment. Health expectations : an international journal of public participation in health care and health policy 27 (2) (2024)
Ying-Tao Lin, Chong-Chong Zhou, Kai Xu, Meng-Die Zhang, Xin Li
Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China. Therapeutic advances in medical oncology 15 (2023)
Yan Jin, Hongtao Li, Pei Zhang, Man Yu, Huan Zhang, Xin Li
The Regulatory Approvals of Immune Checkpoint Inhibitors in China and the United States: A Cross-national Comparison Study. International journal of cancer (2023)
Linlin Shang, Ying-Tao Lin, Wenqing Fang, Yanyan Liu, Yuwen Bao, Xin Li, Yuanyuan Zhang
How National Health Insurance Coverage Policy Affected the Use of Trastuzumab and Rituximab in China: A Bicentric Retrospective Study. Risk management and healthcare policy 16 (2023)
Zhuolin Zhang, Yuwen Bao, Yajie Gu, Mengdie Zhang, Xin Li
Cost-effectiveness Analysis of CYP2C19 Genotype-guided Antiplatelet Therapy for Patients with Acute Minor Ischemic Stroke and High-risk Transient Ischemic Attack in China. British journal of clinical pharmacology (2023)
Yan Jin, Hongtao Li, Pei Zhang, Man Yu, Huan Zhang, Xin Li
The regulatory approvals of immune checkpoint inhibitors in China and the United States: A cross-national comparison study. International journal of cancer (2023)
Chongchong Zhou, Jingxuan Wei, Kai Xu, Ying-Tao Lin, Lingli Zhang, Xin Li
Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China. Risk management and healthcare policy 16 (2023)
Kai Xu, Hong Wu, Chongchong Zhou, Yuwen Bao, Min Yu, Lingli Zhang, Xin Li
Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma. International journal of clinical pharmacy (2023)
Kai Xu, Hong Wu, Chongchong Zhou, Yuwen Bao, Min Yu, Lingli Zhang, Xin Li
Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma. International journal of clinical pharmacy (2023)
Yuwen Bao, Zhuolin Zhang, Xuan He, Lele Cai, Xiao Wang, Xin Li
Cost-Effectiveness of Pyrotinib Plus Capecitabine versus Lapatinib Plus Capecitabine for the Treatment of HER2-Positive Metastatic Breast Cancer in China: A Scenario Analysis of Health Insurance Coverage. Current oncology (Toronto, Ont.) 29 (9) (2022)
Yulei Zhu, Yuqin Ren, Hui Wang, Wenqing Fang, Xinglu Xu, Ying Wang, Huizhen Dai, Xin Li
The impact of policy on availability and price of low-price medicines in public healthcare institutions: A retrospective survey in Nanjing, China. The International journal of health planning and management (2021)
Na Chen, Xin Li, Min Deng, Chang Qing Wang, Chengchao Zhou
Gender difference in unmet need for assistance with activities of daily living among disabled seniors in China : a cross-sectional study. BMJ open 11 (6) (2021)
Ying Wang, Yulei Zhu, Xiaoliang Liu, Xinglu Xu, Wenqing Fang, Xin Li
The Effects of County Public Hospital Reform on the Consumption and Costs of Antibiotics: Evidence from a Quasinatural Experiment in Jiangsu, China. BioMed research international 2020 (2020)
Bin Wan, Nan Fang, Wei Guan, Haixia Ding, Ying Wang, Xin Ge, Hui Liang, Xin Li, Yiyang Zhan
Cost-Effectiveness of Bariatric Surgery versus Medication Therapy for Obese Patients with Type 2 Diabetes in China: A Markov Analysis. Journal of diabetes research 2019 (2019)
Yulei Zhu, Ying Wang, Xiaoluan Sun, Xin Li
Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China. International journal of environmental research and public health 16 (19) (2019)
Ying Wang, Yulei Zhu, Hang Shi, Xiaoluan Sun, Na Chen, Xin Li
The Effect of the Full Coverage of Essential Medicines Policy on Utilization and Accessibility of Primary Healthcare Service for Rural Seniors: A Time Series Study in Qidong, China. International journal of environmental research and public health 16 (22) (2019)